{"id":42313,"date":"2023-11-06T16:31:54","date_gmt":"2023-11-06T16:31:54","guid":{"rendered":"https:\/?p=42313"},"modified":"2023-11-06T16:54:29","modified_gmt":"2023-11-06T16:54:29","slug":"american-analyst-ratings-november-6th-birk-acad-btm-sq-gold","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/","title":{"rendered":"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD)"},"content":{"rendered":"<h2>US Stock Ratings:<\/h2>\n<p>Abcellera Biologics Inc ABCL Benchmark Research Downgrade Buy &#8211; Hold<br \/>\nACADIA Pharmaceuticals Inc ACAD Mizuho Securities Upgraded by Neutral &#8211; Buy 35<br \/>\nAlbemarle Corp ALB UBS Downgrades Neutral 140<br \/>\nAlbemarle Corp ALB Scotia Capital Target Down 190<br \/>\nAllegiant Travel Company ALGT Barclays Maintains Equal-Weight 65<br \/>\nThe Allstate Corporation ALL Raymond James Target Raised by Strong-Buy &#8211; Strong-Buy 155<br \/>\nAMN Healthcare Services Inc AMN Truist Financial Target Lowered by Buy &#8211; Buy 88<br \/>\nAptiv PLC APTV Barclays Maintains Overweight 112<br \/>\nArcutis Biotherapeutics\u00a0Inc ARQT Needham &amp; Company Maintains Buy 8<br \/>\nArcutis Biotherapeutics\u00a0Inc ARQT H.C. Wainwright Maintains Buy 8<br \/>\nAvient Corp AVNT Deutsche Bank Downgrades Hold 37<br \/>\nBank of America Corp BAC Keefe Bruyette &amp; Woods Upgrades Market Perform 30<br \/>\nBall Corporation BALL Barclays Maintains Overweight 60<br \/>\nBrookfield Business Partners LP BBU Scotia Capital Target Down Outperform 25<br \/>\nBloom Energy Corp BE Truist Financial Target Lowered by Hold &#8211; Hold 12<br \/>\nBilibili Inc BILI Mizuho Securities Initiated by Buy 18<br \/>\nBirkenstock Holding plc BIRK Morgan Stanley &amp; Co. Initiates Coverage On Equal-Weight 41<br \/>\nBirkenstock Holding plc BIRK Goldman Sachs &amp; Co. Initiates Coverage On Buy 48.5<br \/>\nBirkenstock Holding plc BIRK BMO Capital Markets Initiates Coverage On Outperform 50<br \/>\nBirkenstock Holding plc BIRK Deutsche Bank Initiated by Buy 43<br \/>\nBirkenstock Holding plc BIRK BNP Paribas Initiated by Neutral 44<br \/>\nBirkenstock Holding plc BIRK J.P. Morgan Chase &amp; Co Initiated by Overweight 48<br \/>\nBirkenstock Holding plc BIRK HSBC Securities (USA) Initiated by Hold 42<br \/>\nBirkenstock Holding plc BIRK Citigroup Initiated by Buy 52<br \/>\nBirkenstock Holding plc BIRK Robert W. Baird &amp; Co. Initiated by Outperform 48<br \/>\nBirkenstock Holding plc BIRK UBS Initiated by Neutral 44<br \/>\nBirkenstock Holding plc BIRK Piper Jaffray Companies Initiated by Overweight 50<br \/>\nBirkenstock Holding plc BIRK Stifel Nicolaus Initiated by Buy 47<br \/>\nBirkenstock Holding plc BIRK Telsey Advisory Group Initiates Coverage On Outperform 47<br \/>\nBirkenstock Holding plc BIRK William Blair &amp; Company Initiated Outperform 0<br \/>\nBirkenstock Holding plc BIRK Williams Trading Initiated by Buy 55<br \/>\nBirkenstock Holding plc BIRK Jefferies &amp; Company Initiated by Buy 50<br \/>\nBirkenstock Holding plc BIRK Bank of America Merrill Lynch Initiated by Neutral 44<br \/>\nBJs Wholesale Club Holdings Inc BJ Deutsche Bank Downgraded by Buy &#8211; Hold 71<br \/>\nBooking Holdings Inc BKNG D. A. Davidson &amp; Co. Upgraded by Neutral &#8211; Buy 3400<br \/>\nBallard Power Systems Inc BLDP Truist Financial Target Lowered by Hold &#8211; Hold 4<br \/>\nBloomin Brands Inc BLMN Raymond James Downgraded by Strong-Buy &#8211; Outperform 28<br \/>\nBloomin Brands Inc BLMN Barclays Maintains Overweight 27<br \/>\nBitcoin Depot Inc. BTM H.C. Wainwright Initiates Coverage On Buy 6<br \/>\nCathay General Bancorp CATY Piper Jaffray Companies Downgrades Underweight 31<br \/>\nCBOE Rosenblatt Securities Maintains Buy 192<br \/>\nC4 Therapeutics\u00a0Inc CCCC Morgan Stanley &amp; Co. Upgrades Equal-Weight 1<br \/>\nCF Industries Holdings Inc CF Scotia Capital Target Down 90<br \/>\nConfluent Inc CFLT RBC Initiated by Outperform 22<br \/>\nCognex Corporation CGNX Raymond James Maintains Strong Buy 60<br \/>\nChurch &amp; Dwight Company Inc CHD Goldman Sachs &amp; Co. Target Lowered by Neutral &#8211; Neutral 89<br \/>\nThe Clorox Company CLX UBS Upgrades Neutral 132<br \/>\nCompass Inc COMP Needham &amp; Company Maintains Buy 4<br \/>\nCorcept Therapeutics Incorporated CORT Truist Financial Upgraded by Hold &#8211; Buy 38<br \/>\nCamden Property Trust CPT UBS Downgraded by Buy &#8211; Neutral 94<br \/>\nCRH PLC ADR CRH Goldman Sachs &amp; Co. Initiated by Neutral 58<br \/>\nCenterspace CSR Compass Point Research &amp; Trading Upgraded by Neutral &#8211; Buy 65<br \/>\nDominion Energy Inc D Barclays Upgraded by Equal Weight &#8211; Overweight 47<br \/>\nTritium Dcfc Ltd DCFC B. Riley Financial Reiterated by Buy &#8211; Neutral 1<br \/>\nDraftKings Inc DKNG Needham &amp; Company Maintains Buy 50<br \/>\nDraftKings Inc DKNG Truist Financial Target Raised by Buy &#8211; Buy 45<br \/>\nEnersys ENS William Blair &amp; Company Downgrades Market Perform<br \/>\nEOG Resources Inc EOG Truist Financial Target Raised by Buy &#8211; Buy 169<br \/>\nEngageSmart LLC ESMT William Blair &amp; Company Downgrades Market Perform 0<br \/>\nEntergy Corporation ETR UBS Upgrade Neutral &#8211; Buy 118<br \/>\nFunko Inc FNKO Goldman Sachs &amp; Co. Target Raised by Sell &#8211; Sell 6.5<br \/>\nTechnipFMC PLC FTI BNP Paribas Downgraded by Outperform &#8211; Neutral 23.5<br \/>\nFortinet Inc FTNT HSBC Securities (USA) Downgrades Hold 49<br \/>\nFortinet Inc FTNT Goldman Sachs &amp; Co. Target Lowered by Buy &#8211; Buy 60<br \/>\nGfl Environmental Holdings Inc GFL Raymond James Target Lowered by Outperform &#8211; Outperform 35<br \/>\nBarrick Gold Corp GOLD TD Securities Target Down Buy 22<br \/>\nHeritage Insurance Hldgs Inc HRTG Truist Financial Target Raised by Buy &#8211; Buy 9<br \/>\nJanus Henderson Group PLC JHG CLSA Upgrade Underperform &#8211; Outperform 0<br \/>\nKeyCorp KEY Keefe Bruyette &amp; Woods Upgrades Outperform 15<br \/>\nWK Kellogg Co KLG Barclays Initiated by Underweight 11<br \/>\nKiora Pharmaceuticals Inc KPRX H.C. Wainwright Maintains Buy 3.5<br \/>\nKontoor Brands Inc KTB Barclays Upgraded by Equal Weight &#8211; Overweight 59<br \/>\nKratos Defense &amp; Security Solutions KTOS Raymond James Maintains Outperform 20<br \/>\nLazydays Holdings Inc LAZY Truist Financial Target Lowered by Hold &#8211; Hold 8<br \/>\nLegend Biotech\u00a0Corp LEGN Goldman Sachs &amp; Co. Initiated by Buy 90.09<br \/>\nMagna International Inc MGA Scotia Capital Target Up Sector Perform 62<br \/>\nIngevity Corp NGVT CJS Securities Downgrade Market Outperform &#8211; Market Perform 49<br \/>\nNRG Energy Inc. NRG UBS Upgraded by Sell &#8211; Neutral 46<br \/>\nNutrien Ltd NTR J.P. Morgan Chase &amp; Co Downgrades Neutral 58<br \/>\nNutrien Ltd NTR Scotia Capital Target Down 75<br \/>\nNEXT plc NXGPF RBC Downgrade Outperform &#8211; Sector Perform<br \/>\nOmega Healthcare Investors Inc OHI Scotia Capital Target Down 32<br \/>\nOmega Healthcare Investors Inc OHI BNP Paribas Downgrades Underperform<br \/>\nOxford Industries Inc OXM B. Riley Financial Initiated Neutral 90<br \/>\nPlains All American Pipeline LP PAA Truist Financial Target Raised by Buy &#8211; Buy 21<br \/>\nPan American Silver Corp. PAAS TD Securities Target Up Buy 17<br \/>\nPlains GP Holdings LP PAGP Truist Financial Target Raised by Buy &#8211; Buy 21<br \/>\nParamount Global Class B PARA Bank of America Merrill Lynch Downgraded by Buy &#8211; Underperform 9<br \/>\nPacira Pharmaceuticals Inc PCRX H.C. Wainwright Maintains Buy 57<br \/>\nPark Hotels &amp; Resorts Inc PK Barclays Upgraded by Equal Weight &#8211; Overweight 19<br \/>\nPlymouth Industrial REIT Inc PLYM Truist Financial Target Lowered by Buy &#8211; Buy 24<br \/>\nPublicis Groupe SA PUBGY Morgan Stanley &amp; Co. Resumed Overweight 0<br \/>\nPioneer Natural Resources Co PXD Susquehanna International Group Downgrades Neutral 250<br \/>\nRestaurant Brands International Inc QSR KeyBanc Capital Markets Target Lowered by Overweight &#8211; Overweight 82<br \/>\nRestaurant Brands International Inc QSR Truist Financial Maintains Buy 83<br \/>\nFerrari NV RACE Barclays Upgrade Equal Weight &#8211; Overweight 0<br \/>\nRetail Opportunity Investments ROIC Bank of America Merrill Lynch Downgraded by Buy &#8211; Neutral 13<br \/>\nRevance The RVNC H.C. Wainwright Maintains Buy 15<br \/>\nSilverBow Resources Inc SBOW Truist Financial Maintains Buy 55<br \/>\nSolarEdge Technologies Inc SEDG Wells Fargo &amp; Company Downgrades Equal-Weight 82<br \/>\nSolarEdge Technologies Inc SEDG HSBC Securities (USA) Downgraded by Buy &#8211; Hold 80<br \/>\nSangamo Therapeutics Inc SGMO Wells Fargo &amp; Company Reiterated by Overweight &#8211; Equal Weight 1<br \/>\nShenzhou International Group Holdings Limited SHZHY Jefferies &amp; Company Downgrade Buy &#8211; Hold<br \/>\nSix Flags Entertainment New SIX KeyBanc Capital Markets Maintains Overweight 28<br \/>\nSL Green Realty Corp SLG Truist Financial Maintains Buy 41<br \/>\nSovos Brands Inc SOVO Telsey Advisory Group Reiterates Outperform 23<br \/>\nSunPower Corporation SPWR Truist Financial Maintains Hold 5<br \/>\nBlock Inc SQ CLSA Upgrades Accumulate 57<br \/>\nStagwell Inc STGW Goldman Sachs &amp; Co. Target Lowered by Buy &#8211; Buy 8<br \/>\nSun Communities Inc SUI Truist Financial Maintains Buy 130<br \/>\nSouthwestern Energy Company SWN Truist Financial Maintains Buy 10<br \/>\nTeleflex Incorporated TFX Truist Financial Maintains Hold 221<br \/>\nTimken Company TKR KeyBanc Capital Markets Maintains Overweight 91<br \/>\nTarga Resources Inc TRGP Truist Financial Maintains Buy 105<br \/>\nSixth Street Specialty Lending Inc TSLX B. Riley Financial Downgrades Neutral 22<br \/>\nUNITIL Corporation UTL Guggenheim Securities Initiated Neutral<br \/>\nVisteon Corp VC Citigroup Upgraded by Neutral &#8211; Buy 149<br \/>\nVermilion Energy Inc. VET Desjardins Securities Upgrade Hold &#8211; Buy<br \/>\nWorld Kinect Corporation WKC Morgan Stanley &amp; Co. Initiated by Equal Weight 24<br \/>\nWPP PLC ADR WPP Morgan Stanley &amp; Co. Resumed Equal-Weight<\/p>\n","protected":false},"excerpt":{"rendered":"<p>US Stock Ratings: Abcellera Biologics Inc ABCL Benchmark Research Downgrade Buy &#8211; Hold ACADIA Pharmaceuticals Inc ACAD Mizuho Securities Upgraded by Neutral &#8211; Buy 35&#8230;<\/p>\n","protected":false},"author":9,"featured_media":42316,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-42313","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD) | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD)\" \/>\n<meta property=\"og:description\" content=\"US Stock Ratings: Abcellera Biologics Inc ABCL Benchmark Research Downgrade Buy &#8211; Hold ACADIA Pharmaceuticals Inc ACAD Mizuho Securities Upgraded by Neutral &#8211; Buy 35...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-06T16:31:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-06T16:54:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/Birkenstock.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gillian Lawrence\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gillian Lawrence\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/\"},\"author\":{\"name\":\"Gillian Lawrence\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042\"},\"headline\":\"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD)\",\"datePublished\":\"2023-11-06T16:31:54+00:00\",\"dateModified\":\"2023-11-06T16:54:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/\"},\"wordCount\":1219,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/\",\"name\":\"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD) | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2023-11-06T16:31:54+00:00\",\"dateModified\":\"2023-11-06T16:54:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042\",\"name\":\"Gillian Lawrence\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g\",\"caption\":\"Gillian Lawrence\"},\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/gillian-lawrence\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD) | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD)","og_description":"US Stock Ratings: Abcellera Biologics Inc ABCL Benchmark Research Downgrade Buy &#8211; Hold ACADIA Pharmaceuticals Inc ACAD Mizuho Securities Upgraded by Neutral &#8211; Buy 35...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2023-11-06T16:31:54+00:00","article_modified_time":"2023-11-06T16:54:29+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/Birkenstock.png","type":"image\/png"}],"author":"Gillian Lawrence","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Gillian Lawrence","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/"},"author":{"name":"Gillian Lawrence","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042"},"headline":"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD)","datePublished":"2023-11-06T16:31:54+00:00","dateModified":"2023-11-06T16:54:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/"},"wordCount":1219,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/","name":"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD) | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2023-11-06T16:31:54+00:00","dateModified":"2023-11-06T16:54:29+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-6th-birk-acad-btm-sq-gold\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Ratings: November 6th (BIRK) (ACAD) (BTM) (SQ) (GOLD)"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042","name":"Gillian Lawrence","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g","caption":"Gillian Lawrence"},"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/gillian-lawrence\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=42313"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42313\/revisions"}],"predecessor-version":[{"id":42315,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42313\/revisions\/42315"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/42316"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=42313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=42313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=42313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}